Minimally invasive and non-surgical aesthetic procedures, like the facial cosmetic procedures and liposuction procedures, account for a majority of the aesthetic procedures performed. Rapid technological advancements, increasing demand for minimally invasive techniques (MIS), increasing awareness of aesthetic procedures, and rising obese population are a few important driving factors for this market.
After the 2008 economic slowdown and recovery of some of the developed countries, significant growth has been noticed in the aesthetics market. Silicone breast implants contribute to approximately 98% of the market in the US alone. Trans-umbilical breast augmentation is expected to fuel the growth of the silicone breast implants market in the US.
France is the leading aesthetic device market in Europe with top surgical procedures like Augmentation Mammaire, Lipoplastie, BlÃÂ©pharoplastie, Rhinoplastie, and Lifting Mammaire, accounting for approximately 20.04%, 16.97%, 13.29%, 7.62%, and 7.08% respectively.
Asia-Pacific region was estimated to have had about 4,336,866 aesthetic procedures in 2011 itself, which was approximately 29.5% of the total aesthetic procedures. Botulinum Toxin Type A (Botox Dysport), a major non-surgical procedure, accounted for 3,179,652 procedures in the same year, followed by Hyaluronic Acid, which accounted for 1,937,576 procedures, globally during 2011.
Rapid technological advances, increasing demand for the use of minimally invasive and non-invasive equipment, widespread awareness about aesthetic procedures, and a rise in obese population are the major driving factors for the growth of the market. As per global estimates, out of the 23 million cosmetic/aesthetic procedures that were conducted till-date, a majority have turned out to be of the minimally invasive type. The minimal and non-invasive procedures account for more than 80% of the cosmetic procedures.
Social stigma concerns and lack of proper reimbursement policies are the main restraints hindering the growth of the market.
The global medical aesthetic devices market can be segmented based on –
The medical aesthetic device market can be segmented based on the products (aesthetic lasers & energy devices, aesthetic implants, facial aesthetics), by procedure (cosmetic and reconstruction), by end user (beauty and home settings) and by geography (North America, Europe, APAC and Rest of the World). Currently, North America is the largest global market, followed by Europe, while APAC is the fastest growing segment.
The medical aesthetic devices market has a great scope for growth if the companies can find ways to capitalize on factors like the increasing beauty consciousness and large disposable incomes. The report provides a detailed overview of each type of aesthetic medical device along with in-depth analysis and company profiles of major players in this market. The current competitive landscape of the market is also elucidated in the report.
Some of the key players in the global medical aesthetic market that are covered in the report include –
Johnson & Johnson
Market analysis for the global medical device market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global medical device market.
Insights of the market in the regions that have the highest potential for growth and to also identify the markets that are still untapped.
Related Topics: Global Anti-Aging market – Growth, Trends and Forecast (2017 – 2022)
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)